Chinese medicine treatment of nasopharyngeal tumors

Many patients with nasopharyngeal tumors are already in the late stage when they go to the hospital for treatment. At this time, doctors will often use traditional Chinese medicine treatment methods for late-stage nasopharyngeal tumors.

A large number of clinical practices have proved that high-dose radiotherapy and chemotherapy for patients in the middle and late stages, or chemotherapy for patients with drug resistance, can only make the weak life more critical and accelerate the death of patients. TCM treatment of nasopharyngeal tumors in the late stage can make up for the deficiencies of surgical treatment, radiotherapy, and chemotherapy. It can not only consolidate the effects of radiotherapy and chemotherapy, but also eliminate the toxic and side effects of radiotherapy and chemotherapy. More importantly, it can cut off the replication function of cancer cells, that is, cut off the important division mode of cancer cells-microtubule protein synthesis, so that the cell volume gradually shrinks, and stable anti-cancer cells are formed in the blood vessels, thereby improving the metabolic function of the human body, that is: by inhibiting the respiration of cancer cells, the cancer cells are ischemic and hypoxic, and no longer fission, so as to achieve the purpose of curing cancer. Scientific experiments have proved that ginsenoside Rh2 not only has the anti-cancer and anti-cancer effects of inhibiting cancer cell proliferation, inhibiting carcinogenic activity, inducing and inducing cancer cell differentiation and apoptosis, resisting tumor invasion and metastasis, and reversing tumor resistance, but also can improve the effect of chemotherapy, overcome the toxic and side effects of chemotherapy, enhance the body's immune function, and fully restore the patient's physical fitness.

Traditional Chinese medicine treatment for late-stage nasopharyngeal tumors can effectively avoid the damage caused by chemotherapy and is more easily accepted by the bodies of late-stage patients.

Nasopharyngeal tumor: http://www..com.cn/zhongliu/bya/byzl.html